SALT LAKE CITY, Dec. 17, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 2013 J.P. Morgan Annual Healthcare Conference, at 9:30 a.m. Pacific Time on Monday, January 7, 2013. The conference is being held at the Westin St. Francis in San Francisco, California.

The presentation will be available to interested parties through a live webcast accessible on the investor relations section of Myriad’s website at

Read More Here